The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Age‐adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer
Open accessAbstract
BACKGROUND.: By using the age‐adjusted Charlson comorbidity index (ACCI), the authors characterized the impact of age and comorbidity on disease progression and overall survival after radical cystectomy (RC) for transitional cell carcinoma of the bladder. Also evaluated was whether ACCI was associated with clinicopathologic and treatment characteristics. METHODS.: The authors evaluated 1121 patients treated by RC for transitional cell carcinoma of the bladder at a single institution (1990–2004). Logistic regression was used to determine the relation between ACCI and clinical features. They evaluated the association between ACCI and overall and progression‐free survival by using multivariate survival‐time models with pathologic stage and nodal status as covariates. RESULTS.: ACCI scores increased during the study period (P = .009). Extravesical disease was present in 43% of patients with ACCI ≤2, 49% with ACCI 3–5, and 56% with ACCI >5 (P = .051). Despite their higher prevalence of extravesical disease, patients with higher ACCI were less likely to have lymph‐node dissection (odds ratio, 0.55 and 0.35, respectively, for ACCI 3–5 and >5 vs ≤2; P = .005), and when it was performed, fewer lymph nodes were evaluated (P < .0005). Patients with higher ACCI were also less likely to have postoperative chemotherapy (odds ratio, 0.70 and 0.66, respectively, for ACCI 3–5 and >5 vs ≤2; P = .04). Higher ACCI was significantly associated with lower overall (P < .005) but not recurrence‐free (P = .17) survival after RC. CONCLUSIONS.: Age and comorbidity among patients who underwent RC at a cancer referral hospital increased with time. Both age and comorbidity were associated with treatment selection and survival and should, therefore, be considered when comparing outcomes after RC. Cancer 2008. © 2008 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today
Doll, R., & Peto, R. (1981) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/66.6.1192 · Cited by 3,927
The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today
Peto, R. (1983) · The Use of Human Cells for the Evaluation of Risk from Physical and Chemical Agents · doi:10.1007/978-1-4757-1117-2_30 · Cited by 3,501
A note on competing risks in survival data analysis
Satagopan, J. M., Ben-Porat, L., Berwick, M., Robson, M., Kutler, D., & Auerbach, A. D. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602102 · Cited by 745
SMOKING AND DEATH RATES—REPORT ON FORTY-FOUR MONTHS OF FOLLOW-UP OF 187,783 MEN
Hammond, E. C. (1958) · Journal of the American Medical Association · doi:10.1001/jama.1958.02990110030007 · Cited by 563
Cancer burden in the aged: an epidemiologic and demographic overview.
Yancik, R. (1997) · PubMed · Cited by 558
Cancer burden in the aged: An epidemiologic and demographic overview
Yancik, R. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971001)80:7<1273::aid-cncr13>3.0.co;2-4 · Cited by 473
Dash, A., Galsky, M. D., Vickers, A. J., Serio, A. M., Koppie, T. M., Dalbagni, G., & Bochner, B. H. (2006) · Cancer · doi:10.1002/cncr.22031 · Cited by 435
Self-citationRepresentation of older patients in cancer treatment trials
Trimble, E. L., Cain, D., Ungerleider, R. S., Friedman, M. A., Carter, C. L., & Freidlin, B. (1994) · Cancer · doi:10.1002/1097-0142(19941001)74:7+<2208::aid-cncr2820741737>3.0.co;2-# · Cited by 343
HERR, H., LEE, C., CHANG, S., LERNER, S., & for the Bladder Cancer Collaborative Group (2004) · Journal of Urology · doi:10.1097/01.ju.0000120289.78049.0e · Cited by 291
Self-citationImpact of comorbidity on lung cancer survival
Tammemagi, C. M., Neslund‐Dudas, C., Simoff, M., & Kvale, P. (2003) · International Journal of Cancer · doi:10.1002/ijc.10882 · Cited by 282
The Impact of Co-morbidity on Life Expectancy Among Men with Localized Prostate Cancer
Albertsen, P. C., Fryback, D. G., Storer, B. E., Kolon, T. F., & Fine, J. (1996) · Journal of Urology · doi:10.1016/s0022-5347(01)65964-0 · Cited by 238
Ouellette, J. R., Small, D. G., & Termuhlen, P. M. (2004) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2004.09.045 · Cited by 163
Comorbidity and survival of elderly head and neck carcinoma patients
Reid, B. C., Alberg, A. J., Klassen, A. C., Samet, J. M., Rozier, R. G., García, I., & Winn, D. M. (2001) · Cancer · Cited by 146
The Impact Of Co-morbid Disease on Cancer Control and Survival Following Radical Cystectomy
MILLER, D. C., Taub, D. A., Dunn, R. L., Montie, J. E., & Wei, J. (2003) · The Journal of Urology · doi:10.1016/s0022-5347(05)64046-3 · Cited by 130
Tobacco smoke and bladder cancer—in the European prospective investigation into cancer and nutrition
Bjerregaard, B. K., Raaschou‐Nielsen, O., Sørensen, M., Frederiksen, K., Christensen, J., Tjønneland, A. M., Overvad, K., Clavel‐Chapelon, F., Nagel, G., Chang-Claude, J. C., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22169 · Cited by 86
Gettman, M. T., Boelter, C., Cheville, J. C., Zincke, H., Bryant, S. C., & Blute, M. L. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000049093.03392.cc · Cited by 86
Hafron, J. M., Mitra, N., Dalbagni, G. M., Bochner, B. H., Herr, H. W., & Donat, S. M. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000154352.54965.14 · Cited by 62
Self-citation
Cited by
Witjes, J. A., Bruins, H. M., Cathomas, R., Compérat, E. M., Cowan, N. C., Gakis, G., Hernández, V., Linares Espinós, E., Lorch, A., Neuzillet, Y., et al. (2021) · European Urology · doi:10.1016/j.eururo.2020.03.055 · Cited by 2,017
Shabsigh, A., Korets, R., Vora, K. C., Brooks, C. M., Cronin, A. M., Savage, C., Raj, G., Bochner, B. H., Dalbagni, G., Herr, H. W., et al. (2009) · European Urology · doi:10.1016/j.eururo.2008.07.031 · Cited by 1,400
Self-citationTreatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline
Chang, S. S., Bochner, B. H., Chou, R., Dreicer, R., Kamat, A. M., Lerner, S. P., Lotan, Y., Meeks, J. J., Michalski, J. M., Morgan, T. M., et al. (2017) · Journal of Urology · doi:10.1016/j.juro.2017.04.086 · Cited by 938
Self-citationThe impact of comorbidity on cancer and its treatment
Sarfati, D., Koczwara, B., & Jackson, C. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21342 · Cited by 680
Lee, R. K., Abol‐Enein, H., Artibani, W., Bochner, B., Dalbagni, G., Daneshmand, S., Fradet, Y., Hautmann, R. E., Lee, C. T., Lerner, S. P., et al. (2014) · BJU International · doi:10.1111/bju.12121 · Cited by 360
Self-citation
Metadata
- Authors
- Koppie, T. M., Serio, A. M., Vickers, A. J., Vora, K., Dalbagni, G., Donat, S. M., Herr, H. W., & Bochner, B. H.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2008-04-10
- Volume
- 112
- Issue
- 11
- Pages
- 2384-2392
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2031967208
- Cited by
- 352
- References
- 19
- FWCI
- 14.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.